Potent immunosuppressive effects by a newly synthesized compound KF20444

Transplantation Proceedings

Volumn 31, Issue 7, 1999, Pages 2792-2793

  Ito, T ^a   Okawa, A ^a   Sawai, T ^a   Yumiba, T ^a   Maeda, A ^a   Tori, M ^a   Nakata, S ^a   Nakajima, H ^b   Sato, S ^b   Matsuda, H ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREQUINAR; IMMUNOSUPPRESSIVE AGENT; KF 20444; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL MEDIATED LYMPHOLYSIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; BIPHENYL COMPOUNDS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED BUF; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032742444     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00570-9     Document Type: Conference Paper

References (7)

1. Schreiber S.L., Crabtree G.R. Immunol Today. 13:1992;136.
2. Sablinski T., Hancock W.W., Tilney N.L., et al. Transplant Rev. 7:1993;129.
3. Chen S.-F., Ruben R., Dexter D. Cancer Res. 46:1986;5014.
4. Ono K., Lindsey E.S. J Thorac Cardiovasc Surg. 57:1969;225.
5. Cramer D.V., Knoop M., Chapman F.A., et al. Transplantation. 54:1992;752.
6. Cramer D.V., Chapman F.A., Jaffee B.D., et al. Transplantation. 54:1992;403.
7. Nozaki S., Ito T., Kamiike W., et al. Transplant Proc. 27:(suppl 1):1994;451.